prikaz prve stranice dokumenta LIJEČENJE HEPATITISA C
  Download
PDF 77.1 KB
Professional paper - Review paper
LIJEČENJE HEPATITISA C
Medicina Fluminensis : Medicina Fluminensis, 43. (2007), 2.; 143-149. urn:nbn:hr:184:815799
Štimac, Davor; Luzer, Jelena; Milić, Sandra

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Štimac, D., Luzer, J. & Milić, S. (2007). LIJEČENJE HEPATITISA C. Medicina Fluminensis : Medicina Fluminensis, 43.. (2.), 143-149. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:815799

Štimac, Davor, et al. "LIJEČENJE HEPATITISA C." Medicina Fluminensis : Medicina Fluminensis, vol. 43., no. 2., 2007, pp. 143-149. https://urn.nsk.hr/urn:nbn:hr:184:815799

Štimac, Davor, Jelena Luzer and Sandra Milić. "LIJEČENJE HEPATITISA C." Medicina Fluminensis : Medicina Fluminensis 43., no. 2. (2007): 143-149. https://urn.nsk.hr/urn:nbn:hr:184:815799

Štimac, D., Luzer, J. and Milić, S. (2007) 'LIJEČENJE HEPATITISA C', Medicina Fluminensis : Medicina Fluminensis, 43.(2.), pp. 143-149. Available at: https://urn.nsk.hr/urn:nbn:hr:184:815799 (Accessed 12 May 2024)

Štimac D, Luzer J, Milić S. LIJEČENJE HEPATITISA C. Medicina Fluminensis : Medicina Fluminensis [Internet]. 2007 June 25 [cited 2024 May 12];43.(2.):143-149. Available at: https://urn.nsk.hr/urn:nbn:hr:184:815799

D. Štimac, J. Luzer and S. Milić, "LIJEČENJE HEPATITISA C", Medicina Fluminensis : Medicina Fluminensis, vol. 43., no. 2., pp. 143-149, June 2007. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:815799. [Accessed: 12 May 2024]

Metadata
Title (croatian)LIJEČENJE HEPATITISA C
Title (english)TREATMENT OF HEPATITIS C
AuthorDavor Štimac
AuthorJelena Luzer
MBZ: 292473
AuthorSandra Milić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Infectology
Abstract (croatian)
SAŽETAK Procjenjuje se da je u svijetu približno 170 milijuna ljudi zaraženo hepatitis C virusom (HCV), a razvoj bolesti iz akutnoga oblika u kronični oblik može se očekivati u 55% do 85% bolesnika. U radu prikazane su dosadašnje spoznaje o terapiji hepatitisa C, uspoređene su postojeće mogućnosti, ukazano je na dosad poznate nuspojave, te je dan uvid u terapiju hepatitisa C u budućnosti. U današnje vrijeme ustaljena terapija HCV infekcije jesu pegilirani interferon i ribavirin u trajanju od 24 tjedna do 48 tjedana, ovisno o genotipu i viralnu odgovoru. U posebnih skupina bolesnika terapija se prilagođuje. U budućnosti očekuje se razvitak novih lijekova, poput specifičnih inhibitora i cjepiva koji će upotpuniti dosadašnje spoznaje i unaprijediti liječenje infekcije HCV-om.
Abstract (english)
SUMMARY It is estimated that the number of hepatitis C virus (HCV) infected patients all round the world amounts to 170 million persons and it is likely to expect that the disease progression from acute to chronic ranges between 55% – 85%. The paper sets out the present knowledge on hepatitis C therapy, compares and contrasts the existing treatment methods, points at the disease side effects and offers an insight into a future therapy trends. Nowadays, the standard HCV infection is cured by pegylated interferon and ribavirin within 24 – 48 weeks, depending on the genotype and viral response. Some special categories of patients require modified therapy. In future it is assumed that a number of new medicines, such as specific inhibitors and particularly vaccines are going to be developed thus enabling a more efficient treatment of HCV infected patients.
Keywords (croatian)
Keywords (english)
Languagecroatian
Publication typeProfessional paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleMedicina Fluminensis : Medicina Fluminensis
Numberingvol. 43., no. 2., pp. 143-149
p-ISSN0025-7729
URN:NBNurn:nbn:hr:184:815799
Publication2007-06-25
Document URLhttp://hrcak.srce.hr/22567
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2017-04-27 15:52:08